Skinvisible Stock Revenue
| SKVI Stock | USD 0.06 0.04 39.00% |
Skinvisible fundamentals help investors to digest information that contributes to Skinvisible's financial success or failures. It also enables traders to predict the movement of Skinvisible OTC Stock. The fundamental analysis module provides a way to measure Skinvisible's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Skinvisible otc stock.
Skinvisible |
Skinvisible OTC Stock Revenue Analysis
Skinvisible's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Skinvisible Revenue | 663.43 K |
Most of Skinvisible's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Skinvisible is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Skinvisible reported 663.43 K of revenue. This is 100.0% lower than that of the Personal Products sector and 99.99% lower than that of the Consumer Staples industry. The revenue for all United States stocks is 99.99% higher than that of the company.
Skinvisible Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Skinvisible's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Skinvisible could also be used in its relative valuation, which is a method of valuing Skinvisible by comparing valuation metrics of similar companies.Skinvisible is currently under evaluation in revenue category among related companies.
Skinvisible Fundamentals
| Return On Asset | 0.0678 | |||
| Profit Margin | (1.88) % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 4.03 M | |||
| Shares Outstanding | 4.54 M | |||
| Shares Owned By Insiders | 4.19 % | |||
| Price To Earning | 4.91 X | |||
| Price To Sales | 1.38 X | |||
| Revenue | 663.43 K | |||
| Gross Profit | 660.13 K | |||
| EBITDA | 158.23 K | |||
| Net Income | (1.07 M) | |||
| Cash And Equivalents | 160.34 K | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 2.58 M | |||
| Debt To Equity | (1.07) % | |||
| Current Ratio | 0.05 X | |||
| Book Value Per Share | (1.38) X | |||
| Cash Flow From Operations | 374.61 K | |||
| Earnings Per Share | (0.19) X | |||
| Beta | -0.27 | |||
| Market Capitalization | 513.09 K | |||
| Total Asset | 227.3 K | |||
| Retained Earnings | (27.83 M) | |||
| Working Capital | (5.53 M) | |||
| Current Asset | 97.12 K | |||
| Current Liabilities | 5.63 M | |||
| Net Asset | 227.3 K |
About Skinvisible Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Skinvisible's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Skinvisible using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Skinvisible based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Skinvisible. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Skinvisible OTC Stock analysis
When running Skinvisible's price analysis, check to measure Skinvisible's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Skinvisible is operating at the current time. Most of Skinvisible's value examination focuses on studying past and present price action to predict the probability of Skinvisible's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Skinvisible's price. Additionally, you may evaluate how the addition of Skinvisible to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |